American International Group, Inc. Embecta Corp. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$12.35 - $19.33 $3,285 - $5,141	-266 Reduced 0.85%	31,153 $413,000
Q4 2023 Feb 13, 2024	SELL	$12.87 - $19.09 $3,359 - $4,982	-261 Reduced 0.82%	31,419 $594,000
Q3 2023 Nov 13, 2023	BUY	$15.0 - $22.17 $10,155 - $15,009	677 Added 2.18%	31,680 $476,000
Q2 2023 Aug 04, 2023	SELL	$21.6 - $30.69 $9,180 - $13,043	-425 Reduced 1.35%	31,003 $669,000
Q1 2023 May 12, 2023	SELL	$23.07 - $32.77 $4,198 - $5,964	-182 Reduced 0.58%	31,428 $883,000
Q4 2022 Feb 10, 2023	SELL	$25.29 - $35.48 $6,196 - $8,692	-245 Reduced 0.77%	31,610 $799,000
Q3 2022 Nov 14, 2022	BUY	$24.0 - $33.42 $17,880 - $24,897	745 Added 2.39%	31,855 $917,000
Q2 2022 Aug 12, 2022	BUY	$24.78 - $33.36 $770,905 - $1.04 Million	31,110 New	31,110 $788,000

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.